Treating Uncomplicated Malaria Using Artemisinin-Based Combination Therapy (ACT)

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
CME 2_thumbnail
Detail Image
CME 2_detail
Book Detail
Upload PDF
Actions
Download in App
Promotional Categories
Featured
Countries of release
Angola
Central African Republic (CAR)
Democratic Republic of the Congo (DRC)
Ghana
India
Kenya
Nigeria
UAE
Zambia
IS_Ebsco
false
Description

Explore this case of uncomplicated malaria in a female patient presenting with cyclic fever, chills, and headache for over three days. Laboratory tests confirmed Plasmodium falciparum infection, and she was treated with a six-dose regimen of an artemisinin-based combination therapy (ACT) in line with WHO guidelines. The therapy has a proven cure rate exceeding 95% in uncomplicated malaria and has been found to be well tolerated and highly effective, as supported by clinical studies in Africa. Discover which ACT was used and learn more about the treatment outcomes in the full case review CME.

Published Date